{
    "cancelStatus": "1",
    "licStatus": "2",
    "cancelDate": "2025-08-25",
    "cancelReason": [
        "841"
    ],
    "otherCancelReason": "",
    "licid": "52028134",
    "licUnit": "1",
    "validDate": "2026-07-21 00:00:00.000",
    "issueDate": "2021-07-21 00:00:00.000",
    "oriIssueDate": "2021-07-21",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202813407",
    "prodNameC": "畢得平凍晶注射劑",
    "prodNameE": "Bendamustine Mylan",
    "indicationsName": [
        "1.Binet分類stage B及C之慢性淋巴球白血病(chronic lymphocytic leukemia, CLL)。2.曾接受至少一種化療之和緩性非何杰金氏淋巴瘤，六個月內曾以rituximab治療失敗之單一治療。3.Bendamustine合併Rituximab適用於先前未曾接受治療的CD20陽性、第III\/IV期和緩性非何杰金氏淋巴癌(non-hodgkin lymphoma, NHL)。Bendamustine合併Rituximab適用於先前未曾接受治療且不適合自體幹細胞移植的第III\/IV期被套細胞淋巴癌(mantle cell lymphoma, MCL)。"
    ],
    "does": "2243",
    "packageUnit": [
        {
            "packageSpec": "每盒100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "25毫克、100毫克",
            "packageUnit": "L2"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "B",
    "mainCategory": "B",
    "drBaseId": "837B81C3-3E98-4230-879A-D37D915D85E8",
    "subCategory": [
        "B02"
    ],
    "ingredientsDesc": [
        "BENDAMUSTINE HYDROCHLORIDE",
        "BENDAMUSTINE HYDROCHLORIDE"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "24 監視期滿學名藥"
    ],
    "applicantName": "台灣邁蘭有限公司",
    "applicantAddr": "臺北市信義區信義路５段7號27樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "8EF4D7DC-6A73-47F8-88A4-4619F86D35CB",
            "factoryCode": "1",
            "factoryName": "MYLAN LABORATORIES LIMITED-OTL",
            "factoryAddr": "PLOT NO. 284B, BOMMASANDRA-JIGANI LINK ROAD, INDUSTRIAL AREA, ANEKAL TALUK, BANGALORE-560105, INDIA",
            "factoryCompanyAddr": null,
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN0921000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1004002510",
            "ingredientsName": "BENDAMUSTINE HYDROCHLORIDE",
            "ingredientsDesc": "BENDAMUSTINE HYDROCHLORIDE",
            "concentDesc": "Bendamustine Hydrochloride Monohydrate (eq. to Bendamustine.....22.7mg)",
            "concent": "25.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        },
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1004002510",
            "ingredientsName": "BENDAMUSTINE HYDROCHLORIDE",
            "ingredientsDesc": "BENDAMUSTINE HYDROCHLORIDE",
            "concentDesc": "Bendamusting Hydrochloride Monohydrate (eq. to Bendamustine.....90.8mg)",
            "concent": "100.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "2",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "暉致醫藥股份有限公司",
            "certNo": "DHA05202813418",
            "approveDocNo": "1110728819",
            "authDate": "2022-11-10",
            "validDate": "2026-07-21"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01AA09"
        }
    ],
    "licBaseId": "5A1CEAD2-9E8C-4107-8BC1-131EC33F2536"
}